News
Serum Institute of India plans clinical trials of second Covid-19 vaccine
Serum Institute of India (SII) has announced plans to conduct clinical trials of another Covid-19 vaccine in the country, with hopes to launch it in June.
Covovax will be the second vaccine from SII (the first being Covishield) developed by...
Clinical Trials
Aizon Launches GxP AI Bioreactor Application for the Pharma Industry to Scale Manufacturing & Quality
Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application adds the bioreactor process to the “Smart Manufacturing” transformation that is accelerating across the Pharma and Biotech industry. Aizon...
Clinical Trials
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
Rigel Pharmaceuticals, Inc. announced it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to support Rigel's ongoing Phase 3 clinical trial to evaluate...
News
Dubai launches Vaccine Logistics Alliance to boost global fight against pandemic
Dubai has launched a logistics alliance that aims to speed up distribution of Covid-19 vaccines around the world through the emirate.
The Dubai Vaccines Logistics Alliance said it would combine Emirates SkyCargo’s air network with DP World’s worldwide network of...
News
Clariant launches natural VOC-trapping DESVOCANT adsorbents for packaging & cargo shipments
Welcome relief from VOCs: Clariant unveils an innovative line of new sustainably-mined clay mineral-based DESVOCANT adsorbents to efficiently reduce the potential exposure of shipment handlers, merchants, and consumers to volatile organic compounds (VOCs) from enclosed manufactured products.
VOCs can accumulate...
News
Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstones Vaccine Platform Technology for HIV Cure
Gilead Sciences, Inc. and Gritstone Oncology, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the companies have entered into a collaboration, option and license agreement to research and develop a vaccine-based immunotherapy...
News
Lilly Partners with Area Health Systems to Help Enable Access to Important Antibody Infusion Therapies for COVID-19 Patients
Eli Lilly and Company has partnered with local health systems to launch dedicated infusion center locations serving central, northern, and now southern Indiana that are intended to provide Hoosiers with access to important COVID-19 treatments. Multiple neutralizing antibody therapies,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















